Light-chain amyloidosis with concomitant symptomatic myeloma (CRAB-SLiM features): clinical characteristics, cytogenetic abnormalities, and outcomes
There was an apparent discrepancy in the distribution and prognostic implication of CA among different plasma cell diseases. Patients with MM-AL had the worst clinical outcomes, requiring extended duration of induction therapy and maintenance therapy.
Authors
- Peng Liu (ORCID: https://orcid.org/0009-0002-5578-1353)
- Wenjing Wang (ORCID: https://orcid.org/0000-0001-6025-9848)
- Chi Zhou (ORCID: https://orcid.org/0000-0002-9162-8594)
- Tianhong Xu (ORCID: https://orcid.org/0000-0001-8493-6874)
- Chenqi Yu
- Jing Li (ORCID: https://orcid.org/0000-0001-5127-9556)
- Pu Wang (ORCID: https://orcid.org/0000-0002-9185-1913)
- Yang Yang
Institutions
- Fudan University (CN)
- Zhongshan Hospital (CN)
- YangPu Geriatric Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1186/s12885-024-13219-0
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Natural Science Foundation of Shanghai